AbbVie is boosting its already strong presence in immunology with the acquisition of Apogee Therapeutics, a clinical-stage biotech whose most advanced drug candidate could bring advantages over several currently available …
Category:
Health
-
-
A simmering dispute between Eli Lilly and the nation’s hospitals boiled over last week. The drugmaker had been threatening to pull 340B discounts from hospitals that refused to submit claims …
-
At a time where vaccine skepticism is growing and the childhood vaccine schedule updated in January, vaccine manufacturers are running into a difficult regulatory review process in the United States. …
-
For decades, employer-sponsored healthcare relied on the same predictable levers to manage spending. Employers rolled out higher deductibles, narrower networks, and increased cost sharing. But a more meaningful shift is …
-
The case that many startups are making for automating the healthcare revenue cycle is pretty straightforward. Claims follow rules, payers adhere to guidelines, and most of this work is repetitive …
-
For both the builders and users of clinical AI, bias remains one of the single greatest issues keeping the industry up at night. The prevailing anxiety revolves around one urgent …
-
America funds the crisis. It’s time to fund the care that prevents it. The post Dying Without a Safety Net appeared first on MedCity News. Staff Reporter
-
In January 2026, CMS launched the Wasteful and Inappropriate Service Reduction (WISeR) model, introducing prior authorization into traditional Medicare for certain services in selected states. However, this controversial program could …
-
An Eli Lilly drug bringing a new approach to blood cancers now has encouraging early data from a small clinical study showing reductions in signs and symptoms of disease, results …
-
If healthcare AI conversations feel more confusing than ever, you’re not alone. Over the past few years, the industry has seen a rapid influx of new AI terminology. What began with discussions …